InteRNA Genomics Joins Applied Biosystems' SOLiD™ Software Community Program
News Jul 23, 2008
InteRNA Genomics B.V. and Applied Biosystems Inc. announce signing of a Software Community Commercial Membership Agreement regarding the exchange of InteRNA's information and software tools related to Applied Biosystems' SOLiD™ technology, InteRNA and Applied Biosystems will co-market InteRNA's small RNA bioinformatics pipeline, miR-Intess™, for users of Applied Biosystems' SOLiD™ System that enables massively parallel sequencing.
The Applied Biosystems SOLiD™ System is a genetic analysis platform that enables ultra-high-throughput (U-HTP) or massively parallel sequencing (MPS) of clonally amplified DNA fragments linked to beads.
The sequencing methodology is based on sequential ligation with dye-labeled oligonucleotides. The ultra-high-throughput capability and accuracy inherent in the SOLiD™ System, coupled with broad application flexibility, provide a system for advancing genome research and personalized genomics, where each individual can have its own genome sequenced.
While the generation of MPS data can be outsourced to a number of sequencing service providers, data processing and interpretation requires highly skilled bioinformaticians and a dedicated computational infrastructure - a challenge for many organizations.
InteRNA Genomics delivers complete, up-to-date and ready-to-interpret analyses of raw sequencing data, allowing the researcher to focus on the biological problem at hand. The informatics solutions are modular enabling development of data analysis pipelines that take into account specifics of every individual project.
The basic miR-Intess™ pipeline generates extensive tabular as well as graphical output. Besides sample and sequencing statistics, comprehensive data on known and candidate novel microRNAs (miRNAs) are provided, allowing simultaneous digital expression profiling and small RNA discovery.
Furthermore, links to miRNA target predictions and public databases are provided. Customized solutions and pipeline extensions are available on request.
"The participation of InteRNA Genomics in our SOLiD™ System software community program is another concrete example of Applied Biosystems' dedication to deliver new, cutting edge products and services to the next generation sequencing community. Our goal is to provide our customers with the best information and software tools available for the analysis of raw data sets," said Roger Canales, Genetic Analysis Software Community Program Manager at Applied Biosystems.
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE